Kara Smigel has been the communications director for the National Cancer Institute (NCI)’s Division of Cancer Prevention since 2000. She coordinates and supports all aspects of communication, including media contacts, writing and editing of reports and responses, divisional websites, and social media. She runs two Twitter feeds, @NCIPrevention and @NCISymptomMgmt, representing prevention, screening, and supportive care research supported by the division. She has been actively involved in all the large, landmark prevention and screening clinical trials, including the ongoing Tomosynthesis Mammographic Imaging Screening Trial (TMIST).
Prior to joining the division in 2000, she worked for 12 years at the NCI Press Office, serving as a Senior Writer/Editor and as an associate editor for the Journal of National Cancer Institute News.
She is a member of the NRG Oncology Communications Committee one of NCI’s National Clinical Trials Network members.